このページの翻訳は実験的なもので、現在開発中です。お待ちしております！

Surgical Innovations Group 将来の成長

Future 基準チェック /06

現在、 Surgical Innovations Groupの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Medical Equipment 収益成長	22.3%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	Low
最終更新日	18 Apr 2024

今後の成長に関する最新情報

Recent updates

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Apr 19

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Dec 29

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Sep 07

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

May 26

業績と収益の成長予測

AIM:SUN - アナリストの将来予測と過去の財務データ ( )GBP Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2024	12	N/A	1	N/A	1
12/31/2023	12	-1	0	0	N/A
9/30/2023	12	0	-1	0	N/A
6/30/2023	12	0	-1	0	N/A
3/31/2023	11	0	-1	0	N/A
12/31/2022	11	0	-1	0	N/A
9/30/2022	11	0	-1	0	N/A
6/30/2022	10	0	-1	0	N/A
3/31/2022	10	0	-1	0	N/A
12/31/2021	9	0	-1	0	N/A
9/30/2021	9	-1	0	0	N/A
6/30/2021	8	-1	0	0	N/A
3/31/2021	7	-2	1	1	N/A
12/31/2020	6	-3	1	1	N/A
9/30/2020	7	-4	1	1	N/A
6/30/2020	8	-5	1	1	N/A
3/31/2020	9	-4	0	1	N/A
12/31/2019	11	-3	0	1	N/A
9/30/2019	11	-1	0	1	N/A
6/30/2019	11	0	0	1	N/A
3/31/2019	11	1	1	1	N/A
12/31/2018	11	1	1	2	N/A
9/30/2018	11	1	1	2	N/A
6/30/2018	11	0	1	2	N/A
3/31/2018	10	0	1	2	N/A
12/31/2017	9	0	1	2	N/A
9/30/2017	8	1	N/A	2	N/A
6/30/2017	7	1	N/A	2	N/A
3/31/2017	6	1	N/A	2	N/A
12/31/2016	6	1	N/A	3	N/A
9/30/2016	6	0	N/A	3	N/A
6/30/2016	6	0	N/A	3	N/A
3/31/2016	6	-1	N/A	2	N/A
12/31/2015	5	-2	N/A	2	N/A
9/30/2015	5	-5	N/A	1	N/A
6/30/2015	5	-9	N/A	0	N/A
3/31/2015	4	-9	N/A	0	N/A
12/31/2014	4	-9	N/A	0	N/A
9/30/2014	5	-6	N/A	0	N/A
6/30/2014	5	-3	N/A	1	N/A
3/31/2014	6	-1	N/A	1	N/A
12/31/2013	7	0	N/A	1	N/A
9/30/2013	8	1	N/A	1	N/A

アナリストによる今後の成長予測

収入対貯蓄率: SUNの予測収益成長が貯蓄率 ( 1.8% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: SUNの収益がUK市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: SUNの収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: SUNの収益がUK市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: SUNの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: SUNの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Surgical Innovations Group 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Surgical Innovations Group plc Provides Revenue Guidance for the Year Ended 31 December 2022

Surgical Innovations Group plc Provides Revenue Guidance for the Six Months to 30 June 2022

Price target decreased to UK£0.033

Surgical Innovations Group plc Provides Revenue Guidance for the Full Year 2021

Recent updates

Surgical Innovations Group plc, Annual General Meeting, Jun 17, 2024

New major risk - Share price stability

Surgical Innovations Group plc's (LON:SUN) Share Price Is Matching Sentiment Around Its Revenues

Full year 2023 earnings released

Surgical Innovations Group plc to Report Fiscal Year 2023 Results on Apr 18, 2024

New minor risk - Financial data availability

New minor risk - Share price stability

Surgical Innovations Group plc Announces Intention of Paul Hardy to Step Down from Position of Independent Non-Executive Director

Investors Don't See Light At End Of Surgical Innovations Group plc's (LON:SUN) Tunnel And Push Stock Down 33%

Charmaine Day Notifies the Board of Her Intention to Step Down from Her Role as Chief Financial Officer of Surgical Innovations Group plc

Surgical Innovations Group plc Announces Board Change

First half 2023 earnings released: EPS: UK£0 (vs UK£0 in 1H 2022)

Surgical Innovations Group plc to Report First Half, 2023 Results on Sep 19, 2023

Returns On Capital At Surgical Innovations Group (LON:SUN) Paint A Concerning Picture

Surgical Innovations Group plc, Annual General Meeting, Jun 27, 2023

Surgical Innovations Group (LON:SUN) Has Some Difficulty Using Its Capital Effectively

Surgical Innovations Group plc Appoints Jonathan Glenn as Senior Independent Non-Executive Director and Chairman-Designate

Full year 2022 earnings released: EPS: UK£0 (vs UK£0 in FY 2021)

Surgical Innovations Group plc Provides Revenue Guidance for the Year Ended 31 December 2022

Less than half of directors are independent

First half 2022 earnings released: EPS: UK£0 (vs UK£0 in 1H 2021)

Surgical Innovations Group plc to Report First Half, 2022 Results on Sep 21, 2022

Surgical Innovations Group plc Ordinary Shares to Be Deleted from OTC Equity

Surgical Innovations Group plc Provides Revenue Guidance for the Six Months to 30 June 2022

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Surgical Innovations Group plc, Annual General Meeting, Jun 27, 2022

Price target decreased to UK£0.033

Less than half of directors are independent

Surgical Innovations Group plc Provides Revenue Guidance for the Full Year 2021

Is Surgical Innovations Group (LON:SUN) Weighed On By Its Debt Load?

Full year 2020 earnings released: UK£0.004 loss per share (vs UK£0.003 loss in FY 2019)

Health Check: How Prudently Does Surgical Innovations Group (LON:SUN) Use Debt?

Full year 2020 earnings released: UK£0.004 loss per share (vs UK£0.003 loss in FY 2019)

Surgical Innovations Group plc to Report Fiscal Year 2020 Results on Mar 25, 2021

Surgical Innovations Group plc Announces New USA Distribution Agreement with Microline Surgical Inc

Surgical Innovations Group plc Announces Adam Power Will Retire as Group Development Director, with Effect from 31 December 2021

Surgical Innovations Group plc Announces Distribution Agreement with Adler Instrument Company Inc

Surgical Innovations Group plc Announces its Collaboration with the Centre for Sustainable Healthcare

First half earnings released

Surgical Innovations Group plc to Report First Half, 2020 Results on Sep 08, 2020

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘